1. |
Klein R, Klein BE, Moss SE. Visual impairment in diabetes[J]. Ophthalmology, 1984, 91(1): 1-9.
|
2. |
Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11[J]. Ophthalmology, 1991, 98(Suppl 5): S807-822.
|
3. |
Chung EJ, Roh MI, Kwon OW, et al. Effects of macular ischemia on the outcome of intravitreal Bevacizumab therapy for diabetic macular edema[J]. Retina, 2008, 28(7): 957-963. DOI: 10.1097/IAE.0b013e3181754209.
|
4. |
Conrath J, Giorgi R, Raccah D, et al. Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment[J]. Eye, 2005, 19(3): 322-326. DOI: 10.1038/sj.eye.6701456.
|
5. |
中华医学会眼科学分会眼底病学组, 中国医师协会眼科医师分会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2022年)[J]. 中华眼底病杂志, 2023, 39(2): 99-124. DOI: 10.3760/cma.j.cn511434-20230110-00018.Fundus Disease Group of Ophthalmological Society of Chinese Medical Association, Fundus Disease Group of Ophthalmologist Branch of Chinese Medical Doctor Association. Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022)[J]. Chin J Ocul Fundus Dis, 2023, 39(2): 99-124. DOI: 10.3760/cma.j.cn511434-20230110-00018.
|
6. |
Yang D, Tang Z, Ran A, et al. Assessment of parafoveal diabetic macular ischemia on optical coherence tomography angiography images to predict diabetic retinal disease progression and visual acuity deterioration[J]. JAMA Ophthalmol, 2023, 141(7): 641-649. DOI: 10.1001/jamaophthalmol.2023.1821.
|
7. |
Shukla D, Kolluru CM, Singh J, et al. Macular ischaemia as a marker for nephropathy in diabetic retinopathy[J]. Indian J Ophthalmol, 2004, 52(3): 205-210.
|
8. |
Shimizu K, Kobayashi Y, Muraoka K. Midperipheral fundus involvement in diabetic retinopathy[J]. Ophthalmology, 1981, 88(7): 601-612. DOI: 10.1016/s0161-6420(81)34983-5.
|
9. |
Ip MS, Domalpally A, Sun JK, et al. Long-term effects of therapy with Ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy[J]. Ophthalmology, 2015, 122(2): 367-374. DOI: 10.1016/j.ophtha.2014.08.048.
|
10. |
Hsieh YT, Alam MN, Le D, et al. OCT angiography biomarkers for predicting visual outcomes after ranibizumab treatment for diabetic macular edema[J]. Ophthalmol Retina, 2019, 3(10): 826-834. DOI: 10.1016/j.oret.2019.04.027.
|
11. |
Byeon SH, Chu YK, Lee H, et al. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes[J]. Ophthalmology, 2009, 116(10): 1949-1959. DOI: 10.1016/j.ophtha.2009.06.066.
|
12. |
Pautler SE. Diabetic macular ischemia[M]//Browning D. Diabetic retinopathy. Springer: New York, 2010: 203-225.
|
13. |
Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report No. 19[J]. Arch Ophthalmol, 1995, 113(9): 1144-1155. DOI: 10.1001/archopht.1995.01100090070025.
|
14. |
Munk MR, Kashani AH, Tadayoni R, et al. Standardization of OCT angiography nomenclature in retinal vascular diseases: first survey results[J]. Ophthalmol Retina, 2021, 5(10): 981-990. DOI: 10.1016/j.oret.2020.12.022.
|
15. |
Magrath GN, Say EAT, Sioufi K, et al. Variability in foveal avascular zone and capillary density using optical coherence tomography angiography machines in healthy eyes[J]. Retina, 2017, 37(11): 2102-2111. DOI: 10.1097/IAE.0000000000001458.
|
16. |
Hormel TT, Jia Y. OCT angiography and its retinal biomarkers[J]. Biomedical Optics Express, 2023, 14(9): 4542-4566. DOI: 10.1364/BOE.495627.
|
17. |
Iafe NA, Phasukkijwatana N, Chen X, et al. Retinal capillary density and foveal avascular zone area are age-dependent: quantitative analysis using optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(13): 5780-5787. DOI: 10.1167/iovs.16-20045.
|
18. |
Sampson DM, Gong P, An D, et al. Axial length variation impacts on superficial retinal vessel density and foveal avascular zone area measurements using optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2017, 58(7): 3065-3072. DOI: 10.1167/iovs.17-21551.
|
19. |
Campbell JP, Zhang M, Hwang TS, et al. Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography[J/OL]. Sci Rep, 2017, 7: 42201[2017-02-10]. https://pubmed.ncbi.nlm.nih.gov/28186181/. DOI: 10.1038/srep42201.
|
20. |
Mendis KR, Balaratnasingam C, Yu P, et al. Correlation of histologic and clinical images to determine the diagnostic value of fluorescein angiography for studying retinal capillary detail[J]. Invest Ophthalmol Vis Sci, 2010, 51(11): 5864-5869. DOI: 10.1167/iovs.10-5333.
|
21. |
Iwasaki M, Inomata H. Relation between superficial capillaries and foveal structures in the human retina[J]. Invest Ophthalmol Vis Sci, 1986, 27(12): 1698-1705.
|
22. |
Provis JM, Hendrickson AE. The foveal avascular region of developing human retina[J]. Arch Ophthalmol, 2008, 126(4): 507-511. DOI: 10.1001/archopht.126.4.507.
|
23. |
Nickla DL, Wallman J. The multifunctional choroid[J]. Prog Retin Eye Res, 2010, 29(2): 144-168. DOI: 10.1016/j.preteyeres.2009.12.002.
|
24. |
Sheth JU, Giridhar A, Rajesh B, et al. Characterization of macular choroidal thickness in ischemic and nonischemic diabetic maculopathy[J]. Retina, 2017, 37(3): 522-528. DOI: 10.1097/IAE.0000000000001172.
|
25. |
Kim JT, Lee DH, Joe SG, et al. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients[J]. Invest Ophthalmol Vis Sci, 2013, 54(5): 3378-3384. DOI: 10.1167/iovs.12-11503.
|
26. |
Xu J, Xu L, Du KF, et al. Subfoveal choroidal thickness in diabetes and diabetic retinopathy[J]. Ophthalmology, 2013, 120(10): 2023-2028. DOI: 10.1016/j.ophtha.2013.03.009.
|
27. |
Sim DA, Keane PA, Fung S, et al. Quantitative analysis of diabetic macular ischemia using optical coherence tomography[J]. Invest Ophthalmol Vis Sci, 2014, 55(1): 417-423. DOI: 10.1167/iovs.13-12677.
|
28. |
Cheung G, Al-Shaaibi M, Teo K. Diabetic macular ischemia and anti-VEGF therapy[M]//Diabetic macular edema. Singapore: Springer Nature Singapore, 2023: 87-94.
|